Cytotoxic T cell polyepitope vaccines delivered by ISCOMs

Vaccine

Volumn 19, Issue 32, 2001, Pages 4669-4675

  Le, Thuy T T ^a   Drane, Debbie ^b   Malliaros, Jim ^b   Cox, John C ^b   Rothel, Linda ^b   Pearse, Martin ^b   Woodberry, Tonia ^a   Gardner, Joy ^a   Suhrbier, Andreas ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CSL LIMITED   (Australia)

Author keywords

Cytotoxic T lymphocyte; ISCOM; Polytope

Indexed keywords

CD8 ANTIGEN; CHROMIUM; EPITOPE; GAMMA INTERFERON; ISCOM; ISCOM VACCINE; ISCOMATRIX; ISCOMATRIX VACCINE; ISCOPREP; ISCOPREP VACCINE; POLYEPITOPE VACCINE; POLYPEPTIDE; POLYTOPE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BIOSYNTHESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA VECTOR; DNA VIRUS; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GENETIC VECTORS; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; ISCOMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0035860585     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00243-2     Document Type: Article

References (21)

1. Immunogenicity of an HIV polytope vaccine containing multiple HLA A2 HIV CD8+ cytotoxic T cell epitopes
2. An HLA A2 polyepitope vaccine for melanoma immunotherapy
3. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: Implications for vaccine design
4. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity
5. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
6. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
7. ISCOMs: An adjuvant with multiple functions
8. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS)
9. A randomised, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM™ vaccines and conventional vaccines
10. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses
11. Studies on experimental adjuvanted influenza vaccines: Comparison of immune stimulating complexes (Iscoms™) and oil-in-water vaccines
12. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
13. Improved media for growing plasmid and cosmid clones
14. Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems
15. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
16. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
17. Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
18. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection
19. CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope